Are you preparing to upgrade your device technical documentation to meet the European Union’s (EU) Medical Device Regulation (MDR) 2017/745 General Safety and Performance Requirements? If so, this webinar will provide best practices and meaningful tips for manufacturers with devices sold under CE marks. NAMSA EMEA regulatory expert, Vincent Legay, will explain how the EU MDR requirements supersede current EU MDD 93/42 and 2007/47 requirements as they relate to Biocompatibility throughout the full medical device lifecycle.
Also discussed will be information on the specific areas of the EU MDR that enhance ISO 10993-1:2018, as well as other guidelines that support EU MDR requirements for deeper assessment, reduction and control of Biological Risk as they relate to patient concerns.
Lastly, critical MDR information will be provided based on NAMSA’s many interactions with EU Notified Bodies and agencies pertaining to the newly expanded requirements.